The drug development sector is embracing technologies and digital methods that were previously not as widely used due to the COVID-19 global health crisis.
Maria I. Florez
Advertisement
Articles by Maria I. Florez
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
FDA Announces New Plausible Mechanism Pathway
2
Roundup: Ovid Therapeutics and Metagenomi Announce 2025 Third Quarter Results and Leadership Updates
3
Pfizer’s Proven Playbook: Buy, Partner, Scale, Spin-Off, Optimize
4
Pharmaceutical Executive Daily: Dr. Richard Pazdur Appointed as Director CDER
5
